Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Carbohydr Res ; 448: 57-66, 2017 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-28623735

RESUMEN

The fungus Penicillium purpurogenum degrades plant cell walls by the action of cellulolytic, xylanolytic and pectinolytic enzymes. The α-D-galactosidase is one of the enzymes which may act on pectin degradation. This enzyme has several biotechnological and medical applications. The aim of this work was to better understand the molecular mechanism of α-D-galactosidase from P. purpurogenum (GALP1). For this purpose, a gene coding for the enzyme was identified from the fungal genome and heterologously expressed in Pichia pastoris. The enzyme belongs to glycosyl hydrolase family 27. The protein of 435 amino acids has an optimum pH and temperature for activity of 5.0 and 50 °C, respectively. The KM for p-nitrophenyl-α-D-galactopyranoside (GalαpNP) is 0.138 mM. The enzyme is inhibited by GalαpNP at concentrations higher than 1 mM, and by the product galactose. A kinetic analysis of product inhibition shows that it is of mixed type, suggesting the presence of an additional binding site in the enzyme. To confirm this hypothesis, a structural model for GALP1 was built by comparative modelling methodology, which was validated and refined by molecular dynamics simulation. The data suggest that galactose may bind to an enzyme alternative pocket promoting structural changes of the active site, thus explaining its inhibitory effect. In silico site-directed mutagenesis experiments highlighted key residues involved in the maintenance of the alternative binding site, and their mutations for Ala predict the formation of proteins which should not be inhibited by galactose. The availability of an α-galactosidase with different kinetic properties to the existent proteins may be of interest for biotechnological applications.


Asunto(s)
Inhibidores Enzimáticos/metabolismo , Inhibidores Enzimáticos/farmacología , Galactosa/metabolismo , Penicillium/enzimología , alfa-Galactosidasa/antagonistas & inhibidores , alfa-Galactosidasa/metabolismo , Sitios de Unión , Concentración de Iones de Hidrógeno , Cinética , Modelos Moleculares , Mutación , Nitrofenilgalactósidos/metabolismo , Nitrofenilgalactósidos/farmacología , Unión Proteica , Conformación Proteica en Hélice alfa , Temperatura , alfa-Galactosidasa/química , alfa-Galactosidasa/genética
2.
Arch Biochem Biophys ; 517(2): 111-22, 2012 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-22155115

RESUMEN

A loop (residues 794-803) at the active site of ß-galactosidase (Escherichia coli) opens and closes during catalysis. The α and ß carbons of Ser-796 form a hydrophobic connection to Phe-601 when the loop is closed while a connection via two H-bonds with the Ser hydroxyl occurs with the loop open. ß-Galactosidases with substitutions for Ser-796 were investigated. Replacement by Ala strongly stabilizes the closed conformation because of greater hydrophobicity and loss of H-bonding ability while replacement with Thr stabilizes the open form through hydrophobic interactions with its methyl group. Upon substitution with Asp much of the defined loop structure is lost. The different open-closed equilibria cause differences in the stabilities of the enzyme·substrate and enzyme·transition state complexes and of the covalent intermediate that affect the activation thermodynamics. With Ala, large changes of both the galactosylation (k(2)) and degalactosylation (k(3)) rates occur. With Thr and Asp, the k(2) and k(3) were not changed as much but large ΔH(‡) and TΔS(‡) changes showed that the substitutions caused mechanistic changes. Overall, the hydrophobic and H-bonding properties of Ser-796 result in interactions strong enough to stabilize the open or closed conformations of the loop but weak enough to allow loop movement during the reaction.


Asunto(s)
Proteínas de Escherichia coli/química , Proteínas de Escherichia coli/metabolismo , Escherichia coli/enzimología , beta-Galactosidasa/química , beta-Galactosidasa/metabolismo , Sustitución de Aminoácidos , Dominio Catalítico/genética , Cristalografía por Rayos X , Inhibidores Enzimáticos/farmacología , Escherichia coli/genética , Proteínas de Escherichia coli/antagonistas & inhibidores , Proteínas de Escherichia coli/genética , Enlace de Hidrógeno , Interacciones Hidrofóbicas e Hidrofílicas , Isopropil Tiogalactósido/farmacología , Cinética , Modelos Moleculares , Mutagénesis Sitio-Dirigida , Nitrofenilgalactósidos/farmacología , Conformación Proteica , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Serina/química , Electricidad Estática , beta-Galactosidasa/antagonistas & inhibidores , beta-Galactosidasa/genética
3.
N Biotechnol ; 28(6): 806-13, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21888996

RESUMEN

After the complete gene of a ß-galactosidase from human isolate Bifidobacterium breve B24 was isolated by PCR and overexpressed in E. coli, the recombinant ß-galactosidase was purified to homogeneity and characterized for the glycoside transferase (GT) and glycoside hydrolase (GH) activities on lactose. One complete ORF encoding 691 amino acids (2,076 bp) was the structural gene, LacA (galA) of the ß-gal gene. The recombinant enzyme shown by activity staining and gel-filtration chromatography was composed of a homodimer of 75 kDa with a total molecular mass of 150 kDa. The K(m) value for lactose (95.58 mM) was 52.5-fold higher than the corresponding K(m) values for the synthetic substrate ONPG (1.82 mM). This enzyme with the optimum of pH 7.0 and 45°C could synthesize approximately 42.00% of GOS from 1M of lactose. About 97.00% of lactose in milk was also quickly hydrolyzed by this enzyme (50 units) at 45°C for 5h to produce 46.30% of glucose, 46.60% of galactose and 7.10% of GOS. The results suggest that this recombinant ß-galactosidase derived from a human isolate B. breve B24 may be suitable for both the hydrolysis and synthesis of galacto-oligosaccharides (GOS) in milk and lactose processing.


Asunto(s)
Proteínas Bacterianas/biosíntesis , Bifidobacterium/enzimología , Proteínas Recombinantes/biosíntesis , beta-Galactosidasa/biosíntesis , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Bifidobacterium/genética , Bifidobacterium/aislamiento & purificación , Inhibidores Enzimáticos/farmacología , Escherichia coli/genética , Industria de Procesamiento de Alimentos , Genes Bacterianos/fisiología , Humanos , Lactosa/química , Lactosa/metabolismo , Nitrofenilgalactósidos/farmacología , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , beta-Galactosidasa/antagonistas & inhibidores , beta-Galactosidasa/química , beta-Galactosidasa/genética
4.
Arch Pharm (Weinheim) ; 344(2): 71-7, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21290422

RESUMEN

This experiment was designed to synthesize 18 kinds of polyhydroxybenzophenones by using Friedel-Crafts reaction, and to measure the inhibitory activity on α-glucosidase with p-nitrophenyl-ß-D-galactopyranoside (PNPG) as a substrate. Here, acarbose (IC(50) = 1674.75 µmol L(-1) ) was used as the reference inhibitor. The results demonstrated that most of the target compounds had remarkable inhibitory activities on α-glucosidase. Among all these compounds, 2,4,4',6-butahydroxydiphenylketone (11) was found to be the most potent α-glucosidase inhibitor with an IC(50) value of 10.62 µmol L(-1) . In addition, we found these compounds were competitive inhibitors through the kinetic analysis. The results suggested that such compounds might be utilized for the development of new candidates for diabetes treatment.


Asunto(s)
Benzofenonas/farmacología , Inhibidores Enzimáticos/farmacología , Inhibidores de Glicósido Hidrolasas , Benzofenonas/síntesis química , Benzofenonas/química , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Técnicas In Vitro , Concentración 50 Inhibidora , Cinética , Estructura Molecular , Nitrofenilgalactósidos/farmacología , Relación Estructura-Actividad
5.
Int J Antimicrob Agents ; 34(4): 360-4, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19619987

RESUMEN

Proteus mirabilis biofilms are a major cause of urinary catheter blockage. Antibiotic-impregnated catheters used to prevent catheter blockage have achieved limited success. Research has examined the efficacy of quorum sensing inhibitors against Pseudomonas aeruginosa biofilms, but there are few reports of the effects of these compounds against crystalline P. mirabilis biofilms. This study examined the effect of two quorum sensing antagonists, p-nitrophenyl glycerol (PNPG) and tannic acid, against crystalline P. mirabilis biofilms. Tannic acid and PNPG were observed to inhibit the quorum sensing system and the formation of P. mirabilis biofilms grown in artificial urine. The success of these compounds provides a possible means of preventing urinary catheter encrustation.


Asunto(s)
Biopelículas , Nitrofenilgalactósidos/farmacología , Proteus mirabilis , Percepción de Quorum/efectos de los fármacos , Taninos/farmacología , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Catéteres de Permanencia/microbiología , Cristalización , Humanos , Proteus mirabilis/efectos de los fármacos , Proteus mirabilis/crecimiento & desarrollo , Cateterismo Urinario/efectos adversos , Orina/microbiología
6.
Environ Microbiol ; 8(6): 1095-104, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16689730

RESUMEN

LecA (PA-IL) is a cytotoxic lectin and adhesin produced by Pseudomonas aeruginosa which binds hydrophobic galactosides with high specificity and affinity. By using a lecA-egfp translation fusion and immunoblot analysis of the biofilm extracellular matrix, we show that lecA is expressed in biofilm-grown cells. In static biofilm assays on both polystyrene and stainless steel, biofilm depth and surface coverage was reduced by mutation of lecA and enhanced in the LecA-overproducing strain PAO-P47. Biofilm surface coverage by the parent strain, PAO-P47 but not the lecA mutant on steel coupons was also inhibited by growth in the presence of either isopropyl-beta-D-thiogalactoside (IPTG) or p-nitrophenyl-alpha-D-galactoside (NPG). Furthermore, mature wild-type biofilms formed in the absence of these hydrophobic galactosides could be dispersed by the addition of IPTG. In contrast, addition of p-nitrophenyl-alpha-L-fucose (NPF) which has a high affinity for the P. aeruginosa LecB (PA-IIL) lectin had no effect on biofilm formation or dispersal. Planktonic growth of P. aeruginosa PAO1 was unaffected by the presence of IPTG, NPG or NPF, nor was the strain able to utilize these sugars as carbon sources, suggesting that the observed effects on biofilm formation were due to the competitive inhibition of LecA-ligand binding. Similar results were also obtained for biofilms grown under dynamic flow conditions on steel coupons, suggesting that LecA contributes to P. aeruginosa biofilm architecture under different environmental conditions.


Asunto(s)
Adhesinas Bacterianas/fisiología , Biopelículas/crecimiento & desarrollo , Pseudomonas aeruginosa/fisiología , Adhesinas Bacterianas/metabolismo , Biopelículas/efectos de los fármacos , Ambiente Controlado , Glicósidos/farmacología , Isopropil Tiogalactósido/farmacología , Nitrofenilgalactósidos/farmacología , Poliestirenos , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/metabolismo , Transducción de Señal/fisiología , Acero Inoxidable
7.
Chem Biol ; 11(9): 1205-15, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15380181

RESUMEN

A series of bivalent ligands of varying length were synthesized to inhibit the receptor-binding process of cholera toxin. Competitive surface receptor binding assays showed that significant potency gains relative to the constituent monovalent ligands were achieved independently from the ability of the extended bivalent ligands to span binding sites within the toxin pentamer. Several models that could account for the unexpected improvement in IC(50) values are examined, taking into account crystallographic analysis of each ligand in complex with the toxin pentamer. Evidence is presented that steric blocking at the receptor binding surface may play a role. The results of our study suggest that the use of relatively short, "nonspanning" bivalent ligands, or monovalent ligands of similar topology and bulk may be an effective way of blocking the interaction of multimeric proteins with their cell surface receptors.


Asunto(s)
Amidas/química , Amidas/farmacología , Toxina del Cólera/antagonistas & inhibidores , Toxina del Cólera/metabolismo , Nitrofenilgalactósidos/química , Nitrofenilgalactósidos/farmacología , Amidas/síntesis química , Secuencia de Aminoácidos , Unión Competitiva , Cristalografía por Rayos X , Concentración 50 Inhibidora , Ligandos , Datos de Secuencia Molecular , Estructura Molecular , Nitrofenilgalactósidos/síntesis química , Piperazinas/síntesis química , Piperazinas/química , Piperazinas/farmacología , Unión Proteica , Receptores de Superficie Celular/antagonistas & inhibidores , Receptores de Superficie Celular/metabolismo
8.
Appl Biochem Biotechnol ; 113-116: 233-50, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15054209

RESUMEN

A beta-glucosidase (BglA, EC 3.2.1.21) gene from the polycentric anaerobic fungus Orpinomyces PC-2 was cloned and sequenced. The enzyme containing 657 amino acid residues was homologous to certain animal, plant, and bacterial beta-glucosidases but lacked significant similarity to those from aerobic fungi. Neither cellulose- nor protein-binding domains were found in BglA. When expressed in Saccharomyces cerevisiae, the enzyme was secreted in two forms with masses of about 110 kDa and also found in two forms associated with the yeast cells. Km and Vmax values of the secreted BglA were 0.762 mM and 8.20 micromol/(min x mg), respectively, with p-nitrophenyl-beta-D-glucopyranoside (pNPG) as the substrate and 0.310 mM and 6.45 micromol/(min.mg), respectively, for the hydrolysis of cellobiose. Glucose competitively inhibited the hydrolysis of pNPG with a Ki of 3.6 mM. Beta-glucosidase significantly enhanced the conversion of cellulosic materials into glucose by Trichoderma reesei cellulase preparations, demonstrating its potential for use in biofuel and feedstock chemical production.


Asunto(s)
Celulosa/metabolismo , Hidrólisis , Neocallimastigales/metabolismo , Proteínas Recombinantes/química , beta-Glucosidasa/química , Secuencia de Aminoácidos , Biotecnología/métodos , Celulosa/química , Clonación Molecular , ADN/química , ADN Complementario/metabolismo , Escherichia coli/metabolismo , Biblioteca de Genes , Concentración de Iones de Hidrógeno , Cinética , Datos de Secuencia Molecular , Nitrofenilgalactósidos/farmacología , Plásmidos/metabolismo , Estructura Terciaria de Proteína , Saccharomyces cerevisiae/metabolismo , Homología de Secuencia de Aminoácido , Factores de Tiempo
9.
Microbiol Res ; 157(2): 103-7, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12002398

RESUMEN

Buchnericin-LB adsorbs to gram-positive but not to gram-negative bacteria. The tested gram-positive bacteria were species of Lactobacillus, Pediococcus, Leuconostoc, Enterococcus, Lactococcus, Listeria, Bacillus, Staphylococcus; gram-negative bacteria belonged to the genera Salmonella, Escherichia, Yersinia and Pseudomonas. Buchnericin-LB adsorption depended on pH but not on time and temperature. Also some anions of salts and lipoteichoic acid reduced or inhibited its adsorption. Treatment of cells and cell walls of sensitive bacteria with detergents, organic solvents or enzymes did not affect subsequent binding of buchnericin-LB. Treatment with buchnericin-LB caused sensitive cells to lose high amounts of intracellular K+ ions and UV-absorbing materials and became more permeable to o-nitrophenol-beta-D-galactopyranoside. Buchnericin-LB (640-2560 AU/ml) decreased the colony forming units (99%) and absorbance values of Listeria monocytogenes and Bacillus cereus. These results indicate that the mode of action of buchnericin-LB is bactericidal and its lethal effect is very rapid.


Asunto(s)
Bacteriocinas/farmacocinética , Lactobacillus/metabolismo , Adsorción/efectos de los fármacos , Bacillus cereus/efectos de los fármacos , Bacillus cereus/crecimiento & desarrollo , Bacteriocinas/metabolismo , Permeabilidad de la Membrana Celular/efectos de los fármacos , Pared Celular/efectos de los fármacos , Pared Celular/metabolismo , Recuento de Colonia Microbiana/métodos , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/crecimiento & desarrollo , Bacterias Grampositivas/efectos de los fármacos , Bacterias Grampositivas/crecimiento & desarrollo , Lactobacillus/crecimiento & desarrollo , Lactobacillus/efectos de la radiación , Lipopolisacáridos/farmacología , Listeria monocytogenes/efectos de los fármacos , Listeria monocytogenes/crecimiento & desarrollo , Nitrofenilgalactósidos/farmacología , Potasio/metabolismo , Ácidos Teicoicos/farmacología , Rayos Ultravioleta
10.
J Virol ; 74(14): 6368-76, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10864647

RESUMEN

Rotavirus infectivity is dependent on the proteolytic cleavage of the VP4 spike protein into VP8* and VP5* proteins. Proteolytically activated virus, as well as expressed VP5*, permeabilizes membranes, suggesting that cleavage exposes a membrane-interactive domain of VP5* which effects rapid viral entry. The VP5* protein contains a single long hydrophobic domain (VP5*-HD, residues 385 to 404) at an internal site. In order to address the role of the VP5*-HD in permeabilizing cellular membranes, we analyzed the entry of o-nitrophenyl-beta-D-galactopyranoside (ONPG) into cells induced to express VP5* or mutated VP5* polypeptides. Following IPTG (isopropyl-beta-D-thiogalactopyranoside) induction, VP5* and VP5* truncations containing the VP5*-HD permeabilized cells to the entry and cleavage of ONPG, while VP8* and control proteins had no effect on cellular permeability. Expression of VP5* deletions containing residues 265 to 474 or 265 to 404 permeabilized cells; however, C-terminal truncations which remove the conserved GGA (residues 399 to 401) within the HD abolished membrane permeability. Site-directed mutagenesis of the VP5-HD further demonstrated a requirement for residues within the HD for VP5*-induced membrane permeability. Functional analysis of mutant VP5*s indicate that conserved glycines within the HD are required and suggest that a random coiled structure rather than the strictly hydrophobic character of the domain is required for permeability. Expressed VP5* did not alter bacterial growth kinetics or lyse bacteria following induction. Instead, VP5*-mediated size-selective membrane permeability, releasing 376-Da carboxyfluorescein but not 4-kDa fluorescein isothiocyanate-dextran from preloaded liposomes. These findings suggest that the fundamental role for VP5* in the rotavirus entry process may be to expose triple-layered particles to low [Ca](i), which uncoats the virus, rather than to effect the detergent-like lysis of early endosomal membranes.


Asunto(s)
Rotavirus/metabolismo , Proteínas no Estructurales Virales/metabolismo , Secuencias de Aminoácidos , Línea Celular , Permeabilidad de la Membrana Celular , Dextranos/química , Fluoresceína-5-Isotiocianato/análogos & derivados , Fluoresceína-5-Isotiocianato/química , Fluoresceínas/química , Colorantes Fluorescentes/química , Liposomas/química , Mutagénesis Sitio-Dirigida , Nitrofenilgalactósidos/farmacología , Fosfatidilcolinas/química , Estructura Terciaria de Proteína , Proteínas de Unión al ARN/metabolismo , Proteínas no Estructurales Virales/química , Proteínas no Estructurales Virales/genética
11.
Biotechnol Bioeng ; 64(3): 322-32, 1999 Aug 05.
Artículo en Inglés | MEDLINE | ID: mdl-10397869

RESUMEN

Recombinant beta-glycosidases from hyperthermophilic Sulfolobus solfataricus (SsbetaGly) and Pyrococcus furiosus (CelB) have been characterized with regard to their potential use in lactose hydrolysis at about 70 degrees C or greater. Compared with SsbetaGly, CelB is approximately 15 times more stable against irreversible denaturation by heat, its operational half-life time at 80 degrees C and pH 5.5 being 22 days. The stability of CelB but not that of SsbetaGly is decreased 4-fold in the presence of 200 mM lactose at 80 degrees C. CelB displays a broader pH/activity profile than SsbetaGly, retaining at least 60% enzyme activity between pH 4 and 7. Both enzymes have a similar activation energy for lactose hydrolysis of approximately 75 kJ/mol (pH 5.5), and this is constant between 30 and 95 degrees C. D-Galactose is a weak competitive inhibitor against the release of D-glucose from lactose (Ki approximately 0.3 M), and at 80 degrees C the ratio of Ki, D-galactose to Km,lactose is 2.5 and 4.0 for CelB and SsbetaGly, respectively. SsbetaGly is activated up to 2-fold in the presence of D-glucose with respect to the maximum rate of glycosidic bond cleavage, measured with o-nitrophenyl beta-D-galactoside as the substrate. By contrast, CelB is competitively inhibited by D-glucose and has a Ki of 76 mM. The transfer of the galactosyl group from lactose to acceptors such as lactose or D-glucose rather than water is significant for both enzymes and depends on the initial lactose concentration as well as the time-dependent substrate/product ratio during batchwise lactose conversion. It is approximately 1.8 times higher for SsbetaGly, compared with CelB. Overall, CelB and SsbetaGly share their catalytic properties with much less thermostable beta-glycosidases and thus seem very suitable for lactose hydrolysis at >/=70 degrees C.


Asunto(s)
Glucosidasas/química , Lactosa/metabolismo , Sulfolobus/enzimología , Temperatura , Compuestos Cromogénicos/metabolismo , Relación Dosis-Respuesta a Droga , Glucosa/farmacología , Concentración de Iones de Hidrógeno , Hidrólisis , Cinética , Lactosa/farmacología , Nitrofenilgalactósidos/farmacología , Factores de Tiempo
12.
J Steroid Biochem Mol Biol ; 68(3-4): 153-62, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10369413

RESUMEN

In order to characterize an involvement of proteoglycans (PG) in the regulation of Leydig cell function, we have examined the effects of para-nitrophenyl-beta-D-xyloside (PNPX), a specific inhibitor of PG synthesis and para-nitrophenyl-beta-D-galactoside (PNPG), an inefficient structural analogue, on testosterone production by purified Leydig cells from immature and mature rats, in the presence or not of various concentrations of hCG during 24 h. Whatever the age, the addition of PNPX induces a decrease of [35S] and [3H] incorporations into cell layer associated-PG; these latter being less numerous (-50 and -25%, respectively in immature and mature rat), and less sulfated (-40%) when compared to control Leydig cells. In immature Leydig cells, the inhibition of PG synthesis decreases both the basal and weakly stimulable-hCG or -(Bu)2cAMP or -LH testosterone synthesis. In mature Leydig cells, the PG inhibition has no effect on testosterone production both in the absence of hCG and in the presence of weak amounts of hCG but increases it in the presence of subsaturating hCG concentrations. Whatever the age, the inhibition of PG synthesis is ineffective in the presence of saturating amounts of either hCG or (Bu)2cAMP. These effects are maintained in the presence of MIX, PMA, but are not observed in the presence of 22R-hydroxycholesterol. Therefore, our results suggest that in rat Leydig cells, the inhibition of PG synthesis affects the signal transduction at a step distal to cyclic AMP and more precisely, the cholesterol supply to the mitochondria by acting on its cellular distribution (free and esterified cholesterol).


Asunto(s)
Glicosaminoglicanos/biosíntesis , Glicósidos/farmacología , Células Intersticiales del Testículo/metabolismo , Proteoglicanos/metabolismo , Testosterona/biosíntesis , 1-Metil-3-Isobutilxantina/farmacología , Animales , Bucladesina/farmacología , Células Cultivadas , Gonadotropina Coriónica/farmacología , AMP Cíclico/metabolismo , Glucosamina/metabolismo , Hidroxicolesteroles/farmacología , Células Intersticiales del Testículo/citología , Células Intersticiales del Testículo/efectos de los fármacos , Hormona Luteinizante/farmacología , Masculino , Nitrofenilgalactósidos/farmacología , Proteoglicanos/biosíntesis , Ratas , Ratas Sprague-Dawley , Maduración Sexual , Transducción de Señal , Sulfatos/metabolismo , Testículo/crecimiento & desarrollo , Acetato de Tetradecanoilforbol/farmacología
13.
J Comp Physiol A ; 182(6): 767-75, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9631555

RESUMEN

Receptor cell responses in the largest labellar (LL) and tarsal (D) taste hairs of the housefly Musca domestica were investigated electrophysiologically using the tip-recording technique. In LL hairs, test series with lactose in concentrations of 12.5-400 mmol.l-1 yielded a threshold concentration around 12 mmol.l-1 and a calculated concentration eliciting half-maximal response of around 40 mmol.l-1, the maximal response varying between 18 and 30 impulses/300 ms. D hairs are more sensitive towards lactose, indicated by a slightly lower threshold and a by 60% higher response to 400 mmol.l-1 lactose. The high variation in the relative stimulating effectiveness of lactose and sucrose and experiments with sugar mixtures imply that these sugars bind to different receptor sites without noticeable cross affinity. A comparison of the concentration response characteristics for sucrose and lactose in LL and D hairs suggests that sucrose can combine with more than one site type, expressed in different proportions in both hair types. Results obtained with p-nitrophenyl-beta-galactoside as stimulus indicate that a beta-galactoside link is not sufficient for a substance to interact specifically with the lactose binding site. The exceptional lactose sensitivity of the sugar cell in M. domestica is discussed in the context of food acquirement and digestion.


Asunto(s)
Células Quimiorreceptoras/efectos de los fármacos , Células Quimiorreceptoras/fisiología , Moscas Domésticas/fisiología , Lactosa/farmacología , Sacarosa/farmacología , Gusto/fisiología , Animales , Carbohidratos/farmacología , Combinación de Medicamentos , Electrofisiología , Femenino , Masculino , Nitrofenilgalactósidos/farmacología
14.
Biochem J ; 325 ( Pt 1): 117-21, 1997 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-9224636

RESUMEN

Second-order rate constants (M-1.s-1) at 25 degrees C and pH 7.5 for inactivation of first-generation (ebga and ebgb), second-generation (ebgab and ebgabcd) and third-generation (ebgabcde) experimental evolvants of the title enzyme by 2',4'-dinitrophenyl 2-deoxy-2-fluoro-beta-D-galactopyranoside are 0.042, 0.30, 10, 24 and 57 respectively. Only partial inactivation is observed, except for ebgabcde. At a single high inactivator concentration, inactivation of the wild-type ebgo is also seen. The changes in sensitivity to the paracatalytic inactivator (over a range of 10(3.3)) are larger than changes in kcat/Km for lactose (over a range of 10(2.7)) or nitrophenyl galactosides (over a range of only 10(1.3)), or changes in degalactosylation rate (over a range of 10(1.7)). These data raise the possibility that evolution in the reverse sense, towards insensitivity to a paracatalytic inactivator with a proportionally lower effect on transformation of substrate, may become a mechanism for the development of bacterial resistance to antibiotics that act by paracatalytic enzyme inactivation.


Asunto(s)
Escherichia coli/enzimología , Isoenzimas/antagonistas & inhibidores , Nitrofenilgalactósidos/farmacología , beta-Galactosidasa/antagonistas & inhibidores , Sitios de Unión , Concentración de Iones de Hidrógeno , Cinética , Estructura Molecular
15.
J Biol Chem ; 272(1): 396-400, 1997 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-8995274

RESUMEN

Human lysosomal beta-galactosidase catalyzes the hydrolysis of beta-galactosides via a double displacement mechanism involving a covalent glycosyl enzyme intermediate. By use of the slow substrate 2,4-dinitrophenyl-2-deoxy-2-fluoro-beta-D-galactopyranoside, a glycosyl enzyme intermediate has been trapped on the enzyme. This has allowed the catalytic nucleophile to be identified as Glu-268 by peptic and tryptic digestion of the inactivated enzyme followed by high performance liquid chromatography-electrospray ionization tandem mass spectrometry of the peptide mixture. This glutamic acid is fully conserved in a sequence-related family of enzymes (Family 35), consistent with its essential role.


Asunto(s)
beta-Galactosidasa/química , Secuencia de Aminoácidos , Animales , Sitios de Unión , Catálisis , Precursores Enzimáticos/química , Gangliosidosis/enzimología , Glutamatos/química , Humanos , Lisosomas/enzimología , Espectrometría de Masas , Ratones , Datos de Secuencia Molecular , Nitrofenilgalactósidos/farmacología , Mapeo Peptídico , Alineación de Secuencia
16.
Biol Pharm Bull ; 19(5): 705-9, 1996 May.
Artículo en Inglés | MEDLINE | ID: mdl-8741579

RESUMEN

A novel beta-glucosidase, which is inducible and capable of catalyzing the hydrolysis of sennosides, was purified from Bifidobacterium sp. strain SEN with Triton X-100 solubilization and DEAE-cellulose column chromatography, by which hydrolytic activities toward sennoside B, 4-methylumbelliferyl beta-glucoside (MUG), and p-nitrophenyl beta-glucoside (pNPG) were obtained together in the same eluted fractions. The activity was stable against detergents such as sodium dodecyl sulfate (SDS) and Triton X-100, but was denatured by SDS and beta-mercaptoethanal when heated. The final preparation was shown to be nearly homogeneous on SDS-polyacrylamide gel electrophoresis (PAGE) either after the enzyme was denatured or when it was not denatured. In the non-denaturing SDS-PAGE, a single protein band hydrolyzed MUG on the gel. In the denaturing SDS-PAGE, the subunit mass of the enzyme was estimated to be 110 kDa. The enzyme was optimally active at pH 6.0 for hydrolysis of sennoside B and MUG. Km values for sennoside B and MUG are 0.94 and 0.53 mM, respectively. The enzyme also catalyzed the hydrolysis of pNPG, amygdalin, geniposide and salicin. It was less active against methyl beta-glucoside and incapable of hydrolyzing cellobiose. The beta-glucosidase activity was inhibited by deoxynojirimycin and p-chloromercuribenzenesulfonic acid, but was less susceptible to several metals (FeSO4, ZnCl2, and CuSO4), and 5,5'-dithio-bis(2-nitrobenzoic acid).


Asunto(s)
Antraquinonas/metabolismo , Bifidobacterium/enzimología , beta-Glucosidasa/aislamiento & purificación , Antraquinonas/aislamiento & purificación , Bifidobacterium/genética , Electroforesis en Gel de Poliacrilamida , Heces/microbiología , Humanos , Concentración de Iones de Hidrógeno , Hidrólisis , Cinética , Nitrofenilgalactósidos/farmacología , Octoxinol/farmacología , Extracto de Senna , Senósidos , Especificidad por Sustrato , beta-Glucosidasa/metabolismo
17.
Biol Pharm Bull ; 19(5): 701-4, 1996 May.
Artículo en Inglés | MEDLINE | ID: mdl-8741578

RESUMEN

Bifidobacterium sp. strain SEN was isolated and characterized by hydrolytic conversion of sennosides to sennidins (Akao et al., Appl. Environ. Microbiol., 60, 1041 (1994)). The sennoside-hydrolyzing capacity of the strain SEN was disappeared following the addition of glucose to the media in spite of good bacterial growth and potent activity hydrolyzing p-nitrophenyl beta-D-glucopyranoside (pNPG). In a fructose-containing medium, no such suppressing effect was shown. Following a 10 h incubation in 50 mM potassium phosphate buffer (pH 7.4), the sennoside-hydrolyzing activity of the bacterium increased, dose-dependently, with the addition of sennoside B. Inhibition of the substrate-induced increase in sennoside-hydrolyzing activity was observed following the addition of some antibiotics (chloramphenicol, streptomycin, and rifampicin). In particular, chloramphenicol completely inhibited the increase of sennoside-hydrolyzing activity while 38% pNPG-hydrolyzing activity remained. It is suggested that the strain SEN produces two different beta-glucosidases of which the sennoside-hydrolyzing enzyme is inducible. In addition, the glucosides pNPG, esculin, salicin, or amygdalin stimulated the induction of the sennoside beta-glucosidase, but less markedly than sennoside. Sennidin A or sugars (glucose, fructose, cellobiose, or maltose) did not induce the enzyme.


Asunto(s)
Antraquinonas/metabolismo , Bifidobacterium/enzimología , beta-Glucosidasa/biosíntesis , Antraquinonas/aislamiento & purificación , Bifidobacterium/genética , Cloranfenicol/farmacología , Inducción Enzimática/efectos de los fármacos , Heces/microbiología , Glucosa/farmacología , Glucósidos/farmacología , Humanos , Nitrofenilgalactósidos/farmacología , ARN Bacteriano/biosíntesis , Extracto de Senna , Senósidos , Especificidad por Sustrato , beta-Glucosidasa/antagonistas & inhibidores
18.
Eur J Biochem ; 232(2): 658-63, 1995 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-7556220

RESUMEN

Kinetic parameters for the inactivation of the 6-phospho-beta-galactosidase of Staphylococcus aureus by a series (fluoro, chloro, bromo) of 2,4-dinitrophenyl-2-deoxy-2-halogeno- galactoside-6-phosphates have been determined. These inhibitors function by the formation of a stabilised glycosyl-enzyme intermediate. Inactivation and reactivation studies indicate that the fluoro derivative is formed most rapidly, but is also hydrolysed fastest. The chloro derivative forms the most stable covalent intermediate. HPLC profiles of V8-protease digestion of native and inhibited protein show significant differences, whereas the inhibited 6-phospho-beta-galactosidase and a point mutant of 6-phospho-beta- galactosidase (E375Q) yield the same proteolytic fragments. The suggestion that E375 is derivatised is strengthened by matrix-assisted laser-desorption ionisation mass spectrometry experiments which show that the two peptides, residues 336-375 and 376-383, are not produced, due to the absence of the expected cleavage at residues 375 and 376. The reason for the altered proteolysis pattern of the inhibited protein is blocking of the respective V8 cleavage site due to the chemical reaction of the inhibitor at position 375. Specific modification of the glycosyl bond between the inhibitor and E375 by aminolysis with benzylamine generated a glutamatic-acid-5-benzylamide complex at that position in the peptide. The Edman derivative of the modified E375 appears to be stable and was isolated by Edman degradation of trypsin-digested V8-peptide. It was shown to be identical to an authentic, synthetic sample. From this, it is evident that E375 is the active-site nucleophile of 6-phospho-galactosidase, consistent with previous findings for enzymes in this family.


Asunto(s)
Glicósido Hidrolasas , Staphylococcus aureus/enzimología , beta-Galactosidasa/antagonistas & inhibidores , beta-Galactosidasa/química , Secuencia de Aminoácidos , Sitios de Unión , Inhibidores Enzimáticos/farmacología , Escherichia coli/enzimología , Glicosilación , Cinética , Datos de Secuencia Molecular , Nitrofenilgalactósidos/farmacología , Mutación Puntual , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Staphylococcus aureus/genética , beta-Galactosidasa/genética
19.
Biochemistry ; 31(37): 8892-7, 1992 Sep 22.
Artículo en Inglés | MEDLINE | ID: mdl-1390676

RESUMEN

Lys319, which is on the same face of putative helix X as His322 and Glu325 in the lactose permease of Escherichia coli, has been replaced with Leu by oligonucleotide-directed, site-specific mutagenesis. Although previous experiments suggested that the mutation does not alter permease activity, we report here that K319L permease is unable to catalyze active lactose accumulation or lactose efflux down a concentration gradient. The mutant does catalyze facilitated influx down a concentration gradient at a significant rate; however, the reaction occurs without concomitant H+ translocation. The mutant also catalyzes equilibrium exchange at about 50% of the wild-type rate, but it exhibits poor counterflow activity. Finally, flow dialysis and photoaffinity labeling experiments with p-nitrophenyl alpha-D-galactopyranoside indicate that K319L permease probably has a markedly decreased affinity for substrate. The alterations described are not due to diminished levels of the mutated protein in the membrane, since immunological studies reveal comparable amounts of permease in wild-type and K319L membranes. It is proposed that Lys319, like Arg302, His322, and Glu325, plays an important role in active lactose transport, as well as substrate recognition.


Asunto(s)
Proteínas de Escherichia coli , Proteínas de Transporte de Membrana/metabolismo , Proteínas de Transporte de Monosacáridos , Simportadores , Marcadores de Afinidad , Transporte Biológico Activo/efectos de los fármacos , Difusión , Escherichia coli/metabolismo , Concentración de Iones de Hidrógeno , Lactosa/metabolismo , Proteínas de Transporte de Membrana/química , Mutagénesis Sitio-Dirigida , Nitrofenilgalactósidos/farmacología , Relación Estructura-Actividad
20.
Indian J Exp Biol ; 30(2): 99-102, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1521873

RESUMEN

Modification of A. conoides beta-glucosidase by diethylpyrocarbonate caused rapid inactivation of the enzyme. The kinetic analyses showed that the inactivation by diethylpyrocarbonate resulted from the modification of an average of one histidine residue per mole of enzyme. The modified enzyme showed an increase in absorbance at 240 nm. Sulphydryl, lysine and tyrosine residues were not modified by diethylpyrocarbonate treatment. The substrate offered significant protection against diethylpyrocarbonates modification. The results indicate that diethylpyrocarbonate was interacting with the enzyme at or near the active site.


Asunto(s)
Dietil Pirocarbonato/farmacología , Histidina/fisiología , beta-Glucosidasa/efectos de los fármacos , Sitios de Unión , Yodoacetamida/farmacología , Hongos Mitospóricos/enzimología , Nitrofenilgalactósidos/farmacología , Fosfato de Piridoxal/farmacología , beta-Glucosidasa/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...